| ID | 1613 |
|---|
| No | 1613 |
|---|
| Brand Name | ALIPRATINIB |
|---|
| Ingredients | PRALSETINIB 100 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 60 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | METASTATIC REAARANGED DURING TRANSFECTION FUSION POSITIVE NON SMALL CELL LUNG CANCER, RET mutant medullary thyroid cancer, RET fusion positive thyroid cancer |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | LIGHT BLUE CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 05 L 1102/24 |
|---|
| FDD Registration Date | 27-MAY-2024 |
|---|
| Expiry Date | 26-MAY-2027 |
|---|
